About Stallergenes greer
Stallergenes Greer: A Global Leader in Allergy Immunotherapy
Stallergenes Greer is a global healthcare company that specializes in the diagnosis and treatment of allergies through allergy immunotherapy (AIT) products and services. With over 60 years of experience, Stallergenes Greer has become a trusted name in the field of allergy treatment, providing innovative solutions to help patients manage their allergies effectively.
The company's mission is to improve the quality of life for people suffering from allergies by developing safe and effective treatments that address the underlying causes of allergic reactions. Stallergenes Greer's products are designed to help patients build up immunity to allergens over time, reducing their sensitivity and minimizing symptoms.
One of Stallergenes Greer's key strengths is its focus on research and development. The company invests heavily in scientific research to develop new treatments for allergies, working closely with leading experts in the field. This commitment to innovation has led to several breakthroughs in allergy treatment, including new forms of immunotherapy that are more convenient and effective than traditional methods.
Stallergenes Greer offers a wide range of AIT products and services designed to meet the needs of patients with different types and severities of allergies. These include sublingual tablets, subcutaneous injections, and customized immunotherapy programs tailored to individual patient needs.
In addition to its core business in AIT products and services, Stallergenes Greer also provides diagnostic testing for allergies through its subsidiary Diater Labs. Diater Labs offers a comprehensive range of diagnostic tests for common allergens such as pollen, dust mites, animal dander, food allergens etc., helping doctors identify specific triggers so they can develop targeted treatment plans for their patients.
Stallergenes Greer operates globally with offices across Europe as well as North America where it has recently expanded into Canada after acquiring an established Canadian pharmaceutical company called ORALair® Canada Inc.. The acquisition will allow them access into Canadian market which will further strengthen their position as one among top players globally within this industry segment.
Overall, Stallergenes Greer is a global leader in allergy immunotherapy with a strong commitment towards improving patient outcomes through innovative solutions backed by extensive research & development efforts. With its broad portfolio offerings catering different types/severity levels associated with various allergic conditions coupled with strategic expansion plans across geographies; it remains well positioned within this highly competitive industry segment poised towards growth opportunities ahead!